| Absorption |
| Blood-Brain Barrier | BBB+ | 0.8892 |
| Human Intestinal Absorption | HIA+ | 0.9931 |
| Caco-2 Permeability | Caco2- | 0.5740 |
| P-glycoprotein Substrate | Non-substrate | 0.8525 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.6574 |
| Non-inhibitor | 0.9226 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8938 |
| Distribution |
| Subcellular localization | Mitochondria | 0.5479 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7919 |
| CYP450 2D6 Substrate | Non-substrate | 0.7644 |
| CYP450 3A4 Substrate | Substrate | 0.5260 |
| CYP450 1A2 Inhibitor | Inhibitor | 0.5805 |
| CYP450 2C9 Inhibitor | Inhibitor | 0.6205 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.8933 |
| CYP450 2C19 Inhibitor | Inhibitor | 0.6788 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.6824 |
| CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.5334 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9022 |
| Non-inhibitor | 0.8024 |
| AMES Toxicity | Non AMES toxic | 0.7031 |
| Carcinogens | Carcinogens | 0.5160 |
| Fish Toxicity | High FHMT | 0.9150 |
| Tetrahymena Pyriformis Toxicity | Low TPT | 0.5974 |
| Honey Bee Toxicity | High HBT | 0.8238 |
| Biodegradation | Not ready biodegradable | 0.7039 |
| Acute Oral Toxicity | I | 0.5159 |
| Carcinogenicity (Three-class) | Non-required | 0.6105 |